Pharmaceutical manufacturers face unprecedented challenges: rising costs, stringent regulations and increasing complexity are forcing drug producers to adapt to ensure efficiency and profitability in competitive markets.
At the same time, drug quality is paramount. Contamination, reduced efficacy or safety issues can undermine patient trust, harm brand reputation and, most critically, jeopardise patient safety.
A factor that impacts both the cost and overall quality of finished drug products are the containers used, which play a vital role in terms of preserving the sterility, stability and efficacy of drug products.
Yet, with increasing cost pressures, some manufacturers may be tempted to opt for cheaper alternatives. Although they may seem appealing in the short-term, such decisions can lead to far-reaching consequences.
So, how do you go about choosing drug containers that maximise product quality whilst maintaining cost efficiency?